The Hodgman Liberal Government’s Controlled Access Scheme is working, with two patients now able to access medical cannabis products under prescription.
Three referrals have been assessed by the Tasmanian Medicines Access and Advisory Committee with the expert panel recently approving two of them.
The third application requires further clinical information before a final decision can be made.
A lot of work has gone into ensuring that Tasmanian patients are able to access unregistered cannabinoid products safely, after other treatment options have been tried unsuccessfully and with the support of specialist medical practitioners.
It is important that a rigorous process is in place to examine applications to the Controlled Access Scheme, and anybody who thinks they may benefit from these products should discuss their situation with their GP.
The CAS is supported by the Tasmanian branch of the Royal Australian College of GPs, Epilepsy Tasmania and the AMA.